Standout Papers

Non-alcoholic fatty liver disease: A patient guideline 2021 2026 2022 2024159
  1. Non-alcoholic fatty liver disease: A patient guideline (2021)
    Sven Francque, Giulio Marchesini et al. JHEP Reports

Immediate Impact

67 standout
Sub-graph 1 of 23

Citing Papers

The first MASH drug therapy on the horizon: Current perspectives of resmetirom
2024 Standout
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
2024 Standout
2 intermediate papers

Works of G.H. Koek being referenced

Non-alcoholic fatty liver disease: A patient guideline
2021 Standout
A survey on non-alcoholic fatty liver disease amongst general practitioners: time to bridge the gap between hepatologists and primary care
2017

Author Peers

Author Last Decade Papers Cites
G.H. Koek 419 429 149 14 634
Anwar Dudekula 385 129 222 20 601
Florence Harnois 257 180 241 15 615
Federica del Genio 536 289 76 22 666
David A. Tendler 329 126 272 14 694
Donald J. Lazas 401 202 240 8 681
Bark Betzel 573 107 80 19 721
Paul C. van de Meeberg 420 187 120 25 670
Peter G. Mavrelis 630 452 60 22 730
Genaro Vázquez‐Elizondo 293 141 165 30 521
A. Castagnini 491 59 197 15 629

All Works

Loading papers...

Rankless by CCL
2026